| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/24/2013 | US20130022648 Granules of porous biocompatible materials |
| 01/24/2013 | US20130022642 Dual Antagonist for TNF-A and IL-21 for Preventing and Treating Autoimmune Diseases |
| 01/24/2013 | US20130022628 Acyl pseudopeptides which carry a functionalized auxiliary arm |
| 01/24/2013 | US20130022620 Assays and methods pertaining to pre-amyloid intermediates |
| 01/24/2013 | US20130022613 Wise/sost nucleic acid sequences and amino acid sequences |
| 01/24/2013 | US20130022611 Methods and compositions for modulating hepsin activation of urokinase-type plasminogen activator |
| 01/24/2013 | US20130022610 Methods of decreasing glycosylated hemoglobin in patients with dyslipidemia |
| 01/24/2013 | US20130022599 Method of treating fibroproliferative disorders |
| 01/24/2013 | US20130022593 Methods of diagnosing endometriosis |
| 01/24/2013 | US20130022592 Continuous subcutaneous insulin infusion methods with a hyaluronan-degrading enzyme |
| 01/24/2013 | US20130022591 Methods of Reducing or Inhibiting Toxic Effects Associated with a Bacterial Infection Using Alkaline Phosphatase |
| 01/24/2013 | US20130022590 Compositions Comprising Zinc Finger Domains and Uses Therefor |
| 01/24/2013 | US20130022589 Methods of treating human papillomavirus |
| 01/24/2013 | US20130022588 Stable formulations of a hyaluronan-degrading enzyme related applications |
| 01/24/2013 | US20130022587 Cycloalkyl-Substituted Imidazole Derivative |
| 01/24/2013 | US20130022578 Methods and system for interfering with viability of bacteria and related compounds and compositions |
| 01/24/2013 | US20130022573 Macrocyclic inhibitors of flaviviridae viruses |
| 01/24/2013 | US20130022572 Organic compounds and their uses |
| 01/24/2013 | US20130022571 Methods for treating viral infection using il-28 and il-29 cysteine mutants |
| 01/24/2013 | US20130022552 Blood clotting composition and method of use |
| 01/24/2013 | US20130022551 DEspR ANTAGONISTS AND AGONISTS AS THERAPEUTICS |
| 01/24/2013 | US20130022540 Methods to facilitate transmission of large molecules across the blood-brain, blood-eye, and blood-nerve barriers |
| 01/24/2013 | US20130020226 Product for parenteral nutrition of obese intensive-care patients |
| 01/24/2013 | DE102011108227A1 Pharmazeutische Zusammensetzung zur Behandlung einer Atemwegserkrankung A pharmaceutical composition for the treatment of a respiratory disease |
| 01/24/2013 | CA2842330A1 Anti-fibrotic peptides and their use in methods for treating diseases and disorders characterized by fibrosis |
| 01/24/2013 | CA2842291A1 Proteolytic extract from bromelain for the treatment of connective tissue disorders |
| 01/24/2013 | CA2842072A1 Methods of treating cardiovascular diseases and predicting the efficacy of exercise therapy |
| 01/24/2013 | CA2842067A1 Novel il-17r-ecd mutants |
| 01/24/2013 | CA2841994A1 Compositions and methods for immunomodulation |
| 01/24/2013 | CA2841955A1 Botulinum toxins for use in a method for treatment of adipose deposits |
| 01/24/2013 | CA2838793A1 Resorption enhancers as additives to improve the oral formulation of non-anticoagulant sulfated polysaccharides |
| 01/23/2013 | EP2548888A1 Periodontal-disease-specific peptide, and treatment and diagnosis of periodontal disease using same |
| 01/23/2013 | EP2548883A2 Peptide compounds that can be used as antibacterial agents |
| 01/23/2013 | EP2548580A1 Pharmaceutical for pseudo-exercise therapy |
| 01/23/2013 | EP2548570A1 Pharmaceutical composition for treating a metabolic syndrome |
| 01/23/2013 | EP2548569A1 Stem cell derived factors for treating pathologic conditions |
| 01/23/2013 | EP2548568A2 Melanocortin receptor ligands |
| 01/23/2013 | EP2548567A1 Polyoma virus JC peptides and proteins in vaccination and diagnostic applications |
| 01/23/2013 | EP2548566A1 Composition for transnasal administration and method for producing same |
| 01/23/2013 | EP2548563A1 Anti-allergic composition |
| 01/23/2013 | EP2547765A1 Beta-propiolactone for inactivation of viruses in pharmaceutical pancreatic enzyme preparations |
| 01/23/2013 | EP2547700A1 Peptides or antibodies which bind to melanoma inhibitory activity (mia) protein |
| 01/23/2013 | EP2547693A2 Integrin interaction inhibitors for the treatment of cancer |
| 01/23/2013 | EP2547692A2 Peptide derivatives, preparation thereof and uses thereof as vectors |
| 01/23/2013 | EP2547356A1 Use of urodilatin for preparing a medicament for the treatment of cardiovascular, renal, pulmonary and neuronal syndromes while avoiding a rebound |
| 01/23/2013 | EP2547355A2 Tfpi inhibitors and methods of use |
| 01/23/2013 | EP2547354A2 Novel immunotherapy against several tumors including gastrointestinal and gastric cancer |
| 01/23/2013 | EP2547353A2 Cancer treatment with recombinant vector |
| 01/23/2013 | EP2547352A1 Combination therapies using cyclosporine and aromatic cationic peptides |
| 01/23/2013 | EP2547351A1 Pharmaceutical compositions of growth hormone secretagogue receptor ligands |
| 01/23/2013 | EP2547333A2 Stable bortezomib formulations |
| 01/23/2013 | EP2547331A1 Gastro-resistant enzyme pharmaceutical compositions |
| 01/23/2013 | EP2547328A2 Ccr7 ligand delivery and co-delivery in immunotherapy |
| 01/23/2013 | EP2261375B1 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in RNA viruses having class I membrane fusogenic envelope proteins |
| 01/23/2013 | EP2158900B1 Polymeric delivery formulations of leuprolide with improved efficacy |
| 01/23/2013 | CN1919339B Cucurbitacin nano preparation comprising protein, preparation method and use thereof |
| 01/23/2013 | CN102893155A Combination therapy and method for assessing resistance to treatment |
| 01/23/2013 | CN102892781A Phospholipid-enriched vesicles bearing tissue factor having haemostatic activities and uses thereof |
| 01/23/2013 | CN102892779A Neuregulin antagonists and use thereof in treating cancer |
| 01/23/2013 | CN102892776A Novel peptide and use thereof |
| 01/23/2013 | CN102892425A Treatment of cardiac conditions |
| 01/23/2013 | CN102892423A Adiponectin production accelerating composition |
| 01/23/2013 | CN102887951A Tuberculosis peptide Ag85B199-207 specific TCR and recombinant retroviral vector and use thereof |
| 01/23/2013 | CN102887948A Antibacterial and immunoregulation polypeptide medicine |
| 01/23/2013 | CN102887945A Bacteriocin and new bacterial isolates |
| 01/23/2013 | CN102887941A PAK (polyester alkyd)/ imidazoline/RGD (arginine-glycine-aspartic acid) ternary conjugate and preparation method and use thereof |
| 01/23/2013 | CN102886045A Method for treating gefitinib resistant cancer |
| 01/23/2013 | CN102886042A Combination containing complex nucleoside, glutathione and yeast extract and application of combination in aspects of alleviating hangover and protecting liver |
| 01/23/2013 | CN102886041A Combination for improving memory and preparation method thereof |
| 01/23/2013 | CN102886040A Combination for enhancing memory and preparation method thereof |
| 01/23/2013 | CN102885794A Buccal interferon tablet and preparation method thereof |
| 01/23/2013 | CN102885782A Growth hormone-containing nanometer medicament microspheres and preparation method thereof |
| 01/23/2013 | CN102885304A BMD (bone mineral density)-increased health food composite and preparation method thereof |
| 01/23/2013 | CN102885301A Composition for enhancing immunity and preparation method thereof |
| 01/23/2013 | CN102440959B Pidotimod liposome solid preparation |
| 01/23/2013 | CN102268414B Coprinus comatus laccase with activity of inhibiting tumor cell proliferation and preparation method thereof |
| 01/23/2013 | CN102229939B Optimized high-activity human lysozyme gene as well as expression vectors and applications thereof |
| 01/23/2013 | CN102226186B Activated Bax gene for treating malignant tumor by taking adenovirus as carrier |
| 01/23/2013 | CN102225198B Anti-tumour medicine composition and preparation method and application thereof |
| 01/23/2013 | CN102205128B Antibacterial peptide preservative, antibacterial peptide preparation containing the same, and preparation method for the antibacterial peptide preparation |
| 01/23/2013 | CN102205111B Application of agrocybe aegerita galactose agglutinin in preparation of anti-HIV (Human Immunodeficiency Virus) infection medicament |
| 01/23/2013 | CN102199615B cDNA sequence coding fibrinolysin, amino acid sequence and applications of sequences |
| 01/23/2013 | CN102153631B Antimicrobial protein with high-efficiency sterilizing activity and application thereof |
| 01/23/2013 | CN101987866B Staphylococcus aureus Efb protein C-end antigen epitope, as well as preparation method and usage thereof |
| 01/23/2013 | CN101979402B Marine cyclic peptide compound and preparation method and use thereof |
| 01/23/2013 | CN101967192B Fusion protein of anti-CD20 antibody fragment and lidamycin (LDM) as well as preparation method and application thereof |
| 01/23/2013 | CN101921329B Alpha interferon mutant and polyethylene glycol derivative thereof |
| 01/23/2013 | CN101906456B Preparation method of antioxidant peptide derived from mytilus coruscus |
| 01/23/2013 | CN101822821B Application of keratinocyte growth factor-2 in preparation of medicines for preventing and curing lung injury |
| 01/23/2013 | CN101797375B Application of MG53 protein for preventing and/or treating myocardial ischemia/reperfusion injury |
| 01/23/2013 | CN101745114B Method for preparing glucose-sensitive insulin controlled-release biological material |
| 01/23/2013 | CN101721682B Application of recombinant human fibroblast growth factor 7 mutant in preparing medicament for treating cervical erosion |
| 01/23/2013 | CN101400787B Mass producing method of growth factor using adipose derived adult stem cells |
| 01/23/2013 | CN101377487B Application of human transcription co-active factor PC4 in preparations for preparing, diagnosing, curing or preventing tumor |
| 01/23/2013 | CN101247821B Improved human interferon molecules and their uses |
| 01/23/2013 | CN101210244B Neutrokine-alpha and Neutrokine-alpha splice variants |
| 01/22/2013 | US8357779 Polymer-von Willebrand factor-conjugates |
| 01/22/2013 | US8357777 Enhanced immunogenicity of tumor associated antigens by addition of αgal epitopes |
| 01/22/2013 | US8357776 Composition for suppressing re-elevation of cholesterol, and usage thereof |
| 01/22/2013 | US8357775 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |